BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18613882)

  • 1. Primary cutaneous T-cell lymphoma, unspecified, exhibiting an aggressive clinical course and a cytotoxic phenotype.
    Yamamoto M; Nakada T; Iijima M
    Int J Dermatol; 2008 Jul; 47(7):720-2. PubMed ID: 18613882
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary cutaneous peripheral T-cell lymphoma, unspecified, with CD8-positive phenotype.
    Watabe H; Kawakami T; Murakami N; Kimura S; Kannari M; Baba T; Soma Y
    Int J Dermatol; 2006 Nov; 45(11):1385-7. PubMed ID: 17076740
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis.
    Laetsch B; Hofbauer G; Kempf W; Burg G; Dummer R
    Dermatology; 2005; 210(4):341-5. PubMed ID: 15942225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
    J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcutaneous anaplastic Kil+ large cell lymphoma with clinical aspect of panniculitis].
    Grange F; Avril MF; Duvillard P; Bosq J; Ollivaud L; Ortoli JC; Guillaume JC
    Ann Dermatol Venereol; 1992; 119(11):890-2. PubMed ID: 1301713
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary cutaneous peripheral T-cell lymphoma, unspecified with an indolent clinical course: a distinct peripheral T-cell lymphoma?
    Ryan AJ; Robson A; Hayes BD; Sheahan K; Collins P
    Clin Exp Dermatol; 2010 Dec; 35(8):892-6. PubMed ID: 20456402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of primary cutaneous natural killer/T-cell lymphoma, nasal type, with indolent clinical course: monoclonal expansion of Epstein-Barr virus genome correlating with the terminal aggressive behaviour.
    Watabe D; Kanno H; Inoue-Narita T; Onodera H; Izumida W; Kowata S; Sawai T; Akasaka T
    Br J Dermatol; 2009 Jan; 160(1):205-7. PubMed ID: 18945315
    [No Abstract]   [Full Text] [Related]  

  • 9. Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
    Hosler GA; Liégeois N; Anhalt GJ; Moresi JM
    J Cutan Pathol; 2008 Nov; 35(11):1063-7. PubMed ID: 18544066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier.
    Ohmatsu H; Sugaya M; Fujita H; Miyagaki T; Kadono T; Maeda D; Takazawa Y; Fukayama M; Tamaki K; Sato S
    Acta Derm Venereol; 2010 May; 90(3):324-5. PubMed ID: 20526566
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.
    Fujimoto N; Kito K; Yoshida T; Tanaka T
    Acta Derm Venereol; 2015 Jan; 95(1):106-7. PubMed ID: 24890876
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
    Marzano AV; Vezzoli P; Fanoni D; Venegoni L; Berti E
    J Am Acad Dermatol; 2009 Aug; 61(2):348-55. PubMed ID: 19615546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
    J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
    Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
    J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study.
    Haghighi B; Smoller BR; LeBoit PE; Warnke RA; Sander CA; Kohler S
    Mod Pathol; 2000 May; 13(5):502-10. PubMed ID: 10824921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A suggested protocol for obtaining high-quality skin metaphases from primary cutaneous T-cell lymphoma.
    Chevret E; Prochazkova M; Beylot-Barry M; Merlio JP
    Cancer Genet Cytogenet; 2006 May; 167(1):89-91. PubMed ID: 16682294
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
    Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
    Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analytical study of 13 cases of cutaneous lymphoma].
    Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
    Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
    [No Abstract]   [Full Text] [Related]  

  • 20. CD8-positive primary cutaneous peripheral T-cell lymphoma, unspecified.
    Rosmaninho A; Sanches M; Alves R; Lima M; Selores M
    Eur J Dermatol; 2012; 22(1):131-2. PubMed ID: 22062773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.